Verdence Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.82M Buy
4,481
+248
+6% +$101K 0.12% 174
2025
Q1
$2.11M Buy
4,233
+456
+12% +$227K 0.16% 140
2024
Q4
$1.96M Sell
3,777
-270
-7% -$140K 0.16% 157
2024
Q3
$2.5M Buy
4,047
+174
+4% +$108K 0.2% 134
2024
Q2
$2.14M Buy
3,873
+2
+0.1% +$1.11K 0.19% 139
2024
Q1
$2.25M Buy
3,871
+3
+0.1% +$1.74K 0.2% 132
2023
Q4
$2.05M Buy
3,868
+58
+2% +$30.8K 0.2% 128
2023
Q3
$1.93M Buy
3,810
+267
+8% +$135K 0.21% 131
2023
Q2
$1.85M Sell
3,543
-120
-3% -$62.6K 0.21% 120
2023
Q1
$2.11M Buy
3,663
+959
+35% +$553K 0.26% 106
2022
Q4
$1.49M Buy
2,704
+888
+49% +$489K 0.18% 130
2022
Q3
$921K Buy
1,816
+106
+6% +$53.8K 0.13% 179
2022
Q2
$929K Buy
1,710
+67
+4% +$36.4K 0.12% 186
2022
Q1
$971K Buy
1,643
+50
+3% +$29.6K 0.11% 200
2021
Q4
$1.06M Buy
1,593
+67
+4% +$44.7K 0.13% 171
2021
Q3
$872K Buy
1,526
+615
+68% +$351K 0.11% 191
2021
Q2
$460K Sell
911
-67
-7% -$33.8K 0.06% 265
2021
Q1
$446K Sell
978
-45
-4% -$20.5K 0.08% 249
2020
Q4
$477K Sell
1,023
-26
-2% -$12.1K 0.09% 215
2020
Q3
$463K Sell
1,049
-2
-0.2% -$883 0.11% 200
2020
Q2
$381K Buy
1,051
+39
+4% +$14.1K 0.09% 211
2020
Q1
$287K Sell
1,012
-122
-11% -$34.6K 0.09% 214
2019
Q4
$369K Buy
1,134
+44
+4% +$14.3K 0.09% 210
2019
Q3
$318K Hold
1,090
0.09% 223
2019
Q2
$320K Buy
1,090
+44
+4% +$12.9K 0.09% 215
2019
Q1
$286K Buy
+1,046
New +$286K 0.08% 210